Skip to main content
TipRanks
Go Ultimate75% OFF

Verrica Pharmaceuticals (VRCA) Q4 2023 Earnings Report

491 Followers

VRCA Q4 2023 EPS Results

Actual EPS
-$5.30
Consensus EPS
-$5.62
Beat/Miss
Beat by +$0.32
One Year Ago EPS
-$1.40

VRCA Q4 2023 Revenue Results

Actual Revenue
$1.99M
Expected Revenue
$975.00K
Beat/Miss
Beat by +$1.01M
YoY Revenue Growth
+2823.53%

Earnings Announcement Details

Quarter
Q4 2023
Date
02/29/2024
Time
Before Open
Conference Call
Thursday, February 29, 2024
VRCA Upcoming Earnings

Verrica Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

VRCA Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

VRCA Earnings History

VRCA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)-0.58--0.57――
Nov 12, 20262026 (Q3)-0.50-0.58-0.03-1833.33% (-0.55)
Aug 06, 20262026 (Q2)-0.39-0.620.02-3200.00% (-0.64)
May 12, 20262026 (Q1)-0.36-0.45-155.00% (+0.55)
Mar 11, 20262025 (Q4)-0.79-0.57-2.476.25% (+1.83)
Nov 14, 20252025 (Q3)-0.06-0.03-4.999.39% (+4.87)
Aug 12, 20252025 (Q2)-0.700.02-3.7100.54% (+3.72)
May 13, 20252025 (Q1)-1.23-1.00-4.477.27% (+3.40)
Mar 11, 20252024 (Q4)-2.52-2.40-5.354.72% (+2.90)
Nov 04, 20242024 (Q3)-3.76-4.90-5.49.26% (+0.50)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed